Results of the UCLA study could lead to new types of drugs, targeting the intestinal cells, to reduce people’s risk of heart attacks and strokes, or to treat other conditions linked to inflammation, including cancer.
The new consortium could not only help generate life-saving treatments, but also create significant economic activity from spin-off companies to licenses and collaborations with industry.
Two priorities for the fiscal year 2017 competition were north campus-led research projects and projects involving big data and related tools and capabilities.
By showing that stress levels can be quantified by a simple urine test, and that this test helps predict disease, this work could lead to strategies for prevention of coronary heart disease and heart attacks.
Findings help UCLA-led researchers better understand congenital Zika virus syndrome — a pattern of birth defects found among fetuses and babies infected with the virus.
The Semel Institute for Neuroscience and Human Behavior is one of a handful of hospitals and clinics nationwide that offer a treatment that works in a fundamentally different way than drugs.
What are the prospects for young men and women who grow up in and then age out of the juvenile justice system? Research and the media paint a bleak picture for those whose adolescent years have been intertwined with incarceration.
Minimum parking requirements — rules that are imposed on developers of apartment buildings, among other builders, to provide parking spaces for their tenants — are partly to blame for the crisis in affordable housing in cities like Los Angeles.
A team of UCLA scientists is testing an experimental drug that could one day result in a treatment for osteoporosis, which affects more than 200 million people worldwide.
Study showed air, soil and water from city parks in Los Angeles, San Diego, Fresno and Bakersfield contained high quantities of the genes in bacteria cells.
The new technique for breaking carbon–hydrogen bonds and making carbon–carbon bonds uses catalysts made of silicon and boron, which are abundant and inexpensive.
Test developed by UCLA researchers would help physicians determine which people may be more treatable with an antibiotic that has not been recommended since 2007.